Get the latest tech news
Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M
23andMe was sold by bankruptcy auction, a year after the company had a massive data breach.
Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as part of the deal. Regeneron said in its statement that as the named buyer in the bankruptcy auction, it “intends to ensure compliance” with 23andMe’s privacy policies and laws regarding customer data.
Or read this on TechCrunch
